Bruges, Belgium

Rein Verbeke

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Universiteit Gent. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rein Verbeke. Retrieved from https://idiyas.com/inventor/rein-verbeke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rein Verbeke: Innovator in Therapeutic Nanoparticles

Introduction

Rein Verbeke is a notable inventor based in Bruges, Belgium. He has made significant contributions to the field of therapeutic nanoparticles, particularly in the optimized delivery of nucleic acids. His work is crucial for advancements in immunotherapy and vaccination.

Latest Patents

Rein Verbeke holds a patent for "Therapeutic nanoparticles and methods of use thereof." This invention relates to a method and composition designed for optimized intracellular delivery of nucleic acids, specifically mRNA. The composition may also include a glycolipid antigen and combinations with checkpoint inhibitors. The method targets antigen presenting cells, making it especially useful for immunotherapy and vaccination purposes. He has 1 patent to his name.

Career Highlights

Rein Verbeke is affiliated with Universiteit Gent, where he continues to engage in innovative research. His work has garnered attention for its potential applications in medical therapies.

Collaborations

He has collaborated with notable colleagues, including Heleen Dewitte and Stefaan De Smedt, contributing to the advancement of their shared research goals.

Conclusion

Rein Verbeke's contributions to the field of therapeutic nanoparticles highlight his role as an innovator in medical technology. His work promises to enhance the effectiveness of immunotherapy and vaccination strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…